
Amanda Marie Haney
Examiner (ID: 15654, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1025 |
| Issued Applications | 286 |
| Pending Applications | 134 |
| Abandoned Applications | 624 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19013280
[patent_doc_number] => 11920198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Method and kit for identifying gene mutations
[patent_app_type] => utility
[patent_app_number] => 17/374478
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4581
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374478 | Method and kit for identifying gene mutations | Jul 12, 2021 | Issued |
Array
(
[id] => 19932034
[patent_doc_number] => 12305233
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-05-20
[patent_title] => Ultra-high-throughput assay for telomerase repeat addition processivity
[patent_app_type] => utility
[patent_app_number] => 17/372255
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4126
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1022
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372255 | Ultra-high-throughput assay for telomerase repeat addition processivity | Jul 8, 2021 | Issued |
Array
(
[id] => 17357167
[patent_doc_number] => 20220017963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Methods, Compositions and Systems for Detecting PNPLA3 Allelic Variants
[patent_app_type] => utility
[patent_app_number] => 17/368610
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368610 | Methods, Compositions and Systems for Detecting PNPLA3 Allelic Variants | Jul 5, 2021 | Pending |
Array
(
[id] => 17836360
[patent_doc_number] => 20220273665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHODS OF TREATING INFLAMMATORY BOWEL DISEASES THAT TARGET RIPK2
[patent_app_type] => utility
[patent_app_number] => 17/357625
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357625 | METHODS OF TREATING INFLAMMATORY BOWEL DISEASES THAT TARGET RIPK2 | Jun 23, 2021 | Abandoned |
Array
(
[id] => 17142067
[patent_doc_number] => 20210310079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/353279
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353279 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Jun 20, 2021 | Pending |
Array
(
[id] => 17414403
[patent_doc_number] => 20220049307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => MITOCHONDRIAL MARKERS OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/337355
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337355 | Mitochondrial markers of neurodegenerative diseases | Jun 1, 2021 | Issued |
Array
(
[id] => 19013278
[patent_doc_number] => 11920196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Circulating microRNAs in knee osteoarthritis and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/337163
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 18189
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337163 | Circulating microRNAs in knee osteoarthritis and uses thereof | Jun 1, 2021 | Issued |
Array
(
[id] => 18452085
[patent_doc_number] => 20230193364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => A GENETIC TEST TO PREDICT ANTI-TNF DRUG RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/999616
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999616 | A GENETIC TEST TO PREDICT ANTI-TNF DRUG RESPONSE | May 20, 2021 | Pending |
Array
(
[id] => 17292605
[patent_doc_number] => 20210388444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => FUS/TLS-BASED COMPOUNDS AND METHODS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED MOTOR NEURON DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/325279
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325279 | FUS/TLS-BASED COMPOUNDS AND METHODS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED MOTOR NEURON DISEASES | May 19, 2021 | Pending |
Array
(
[id] => 20272270
[patent_doc_number] => 12442041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Epigenetic biomarker composition for diagnosing Down syndrome, and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/003658
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4926
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003658 | Epigenetic biomarker composition for diagnosing Down syndrome, and use thereof | May 6, 2021 | Issued |
Array
(
[id] => 17022644
[patent_doc_number] => 20210246515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/241671
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241671 | COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER | Apr 26, 2021 | Abandoned |
Array
(
[id] => 17188566
[patent_doc_number] => 20210335451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => TRANSCRIPTOMIC SIGNATURE FOR THE PROGNOSIS AND TREATMENT SELECTION FOR CERVICAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/240386
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240386 | TRANSCRIPTOMIC SIGNATURE FOR THE PROGNOSIS AND TREATMENT SELECTION FOR CERVICAL CANCER | Apr 25, 2021 | Abandoned |
Array
(
[id] => 19196591
[patent_doc_number] => 11993820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Methods of detecting MLH1 methylation
[patent_app_type] => utility
[patent_app_number] => 17/234297
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 11995
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 389
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234297 | Methods of detecting MLH1 methylation | Apr 18, 2021 | Issued |
Array
(
[id] => 18879566
[patent_doc_number] => 20240002935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/995950
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 468
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995950 | GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS | Apr 8, 2021 | Pending |
Array
(
[id] => 17126577
[patent_doc_number] => 20210301346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF OPIOID-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/301660
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301660 | Serotonin transporter gene and treatment of opioid-related disorders | Apr 8, 2021 | Issued |
Array
(
[id] => 18485340
[patent_doc_number] => 20230212675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => KIT OR DEVICE AND METHOD FOR DETECTING HIPPOCAMPAL ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/915682
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915682 | KIT OR DEVICE AND METHOD FOR DETECTING HIPPOCAMPAL ATROPHY | Mar 30, 2021 | Pending |
Array
(
[id] => 16964221
[patent_doc_number] => 20210215720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS
[patent_app_type] => utility
[patent_app_number] => 17/193907
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193907
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/193907 | PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS | Mar 4, 2021 | Pending |
Array
(
[id] => 18726320
[patent_doc_number] => 20230340595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => USE OF PLURIPOTENT MARKERS TO DETECT CONTAMINATING RESIDUAL UNDIFFERENTIATED PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/908750
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908750 | USE OF PLURIPOTENT MARKERS TO DETECT CONTAMINATING RESIDUAL UNDIFFERENTIATED PLURIPOTENT STEM CELLS | Feb 28, 2021 | Abandoned |
Array
(
[id] => 18567475
[patent_doc_number] => 20230257809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Non-Invasive Successfulness Test of In Vitro Fertilization Process
[patent_app_type] => utility
[patent_app_number] => 17/905624
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905624 | Non-Invasive Successfulness Test of In Vitro Fertilization Process | Feb 28, 2021 | Pending |
Array
(
[id] => 18322697
[patent_doc_number] => 20230120825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => Compositions, Methods, and Systems for Paternity Determination
[patent_app_type] => utility
[patent_app_number] => 17/802934
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802934 | Compositions, Methods, and Systems for Paternity Determination | Feb 25, 2021 | Pending |